| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.4 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.24 | 0.5 |